IP Library Granted Patent US 10,139,402
Granted Patent B2
US 10,139,402 · App. 15/035,094 · Granted Nov 27, 2018

Separation method, detection method, signal measurement method, method for determining disease, method for evaluating drug efficacy of disease treatment drug, kit, and liquid composition

Inventors: Hiroya Fujii (Minato-ku, JP); Motoaki Mizuuchi (Minato-ku, JP); Tetsuji Yamaguchi (Minato-ku, JP); Hiroki Abe (Minato-ku, JP)
Assignees: JSR CORPORATION; JSR Life Sciences Corporation
G01N33/5432C12Q1/6804G01N2800/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,139,402
App. No.
15/035,094
Granted
Nov 27, 2018
Kind
B2
Abstract

A method for separating a vesicle having a lipid bilayer membrane from a biological sample, includes forming a complex of a vesicle and a solid phase carrier by bringing the biological sample containing the vesicle having the lipid bilayer membrane into contact with the solid phase carrier to which a ligand for recognizing a surface antigen present on a surface of the vesicle is bound. The complex is washed. The forming is performed in the presence of a nonionic surfactant which does not comprise an aromatic group to reduce an aggregation of the complex.

Claims (14)

1. A method for separating a vesicle having a lipid bilayer membrane from a biological sample, the method comprising:

forming a complex of a vesicle and a solid phase carrier by bringing the biological sample comprising the vesicle having the lipid bilayer membrane into contact with the solid phase carrier to which a ligand for recognizing a surface antigen present on a surface of the vesicle and is bound, and

washing the complex,

wherein the forming and the washing is performed in the presence of a nonionic surfactant to reduce an aggregation of the complex,

wherein the nonionic surfactant is one or more selected from the group consisting of a polyalkylene glycol ethylene oxide adduct, a fatty acid ester of sorbitan, a fatty acid ester of sorbitol, an ethylene oxide adduct of sorbitan fatty acid ester, and an ethylene oxide adduct of sorbitol fatty acid ester.

2. The method according to claim 1 , wherein the nonionic surfactant is a block copolymer of a polyalkylene glycol ethylene oxide adduct.

3. The method according to claim 1 , wherein the nonionic surfactant is a block copolymer comprising a block formed of a polyethylene oxide and a block formed of a polyalkylene oxide and having 3 or more carbon atoms in the alkylene.

4. The method according to claim 1 , wherein the biological sample is a body fluid or a cell culture supernatant.

5. The method according to claim 1 , wherein the vesicle is an exosome.

6. The method according to claim 1 , wherein the surface antigen is an antigen protein present on a surface of an exosome and the ligand is an antibody which recognizes the antigen protein.

7. The method according to claim 1 , wherein the solid phase carrier is a magnetic particle.

8. The method according to claim 7 , wherein the washing comprises:

collecting the magnetic particle by magnetic force to separate the magnetic particle from a liquid phase, and

dispersing the magnetic particle that is separated by the collecting in a washing solution.

Assignments (5)
CHANGE OF NAME Recorded Mar 25, 2026
From: JSR LIFE SCIENCES CORPORATION
To: MBL MATERIALS CO., LTD.
Reel/Frame 075228/0228 →
CHANGE OF ADDRESS Recorded Mar 25, 2026
From: MBL MATERIALS CO., LTD.
To: MBL MATERIALS CO., LTD.
Reel/Frame 075228/0238 →
CHANGE OF NAME Recorded Sep 22, 2025
From: JICC-02 CORPORATION
To: JSR CORPORATION
Reel/Frame 072326/0282 →
MERGER Recorded Sep 22, 2025
From: JSR CORPORATION
To: JICC-02 CORPORATION
Reel/Frame 072935/0152 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2016
From: FUJII, HIROYA; MIZUUCHI, MOTOAKI; YAMAGUCHI, TETSUJI; ABE, HIROKI
To: JSR CORPORATION; JSR LIFE SCIENCES CORPORATION
Reel/Frame 039496/0865 →
Priority Claims (1)
JP 2013-230530 · Nov 6, 2013 · national
Continuity (2)
Provisional Application 61968967 · Mar 21, 2014
Related Publication 20160349246A1 · Dec 1, 2016
Cited By (1)
US 12,474,341